Dr. Mark Gonzalgo is professor and vice chair of urology and director of the urologic oncology fellowship program at the University of Miami. He also serves as Executive Director of Perioperative Surgical Services for the University of Miami Health System. Dr. Gonzalgo is a urologic oncologist with expertise in robotic surgical approaches for the treatment of prostate, bladder, and kidney cancers. Dr. Gonzalgo was recruited to the University of Miami from Stanford where he served as Director of Robotic-Assisted Urologic Cancer Surgery. He was previously on faculty at Johns Hopkins where he was Associate Professor of Urology and Director of the Fellowship Program in Urologic Oncology at The Brady Urological Institute.
He received his undergraduate degree with honors from the University of California at Berkeley and completed medical and graduate school at the USC Keck School of Medicine. Dr. Gonzalgo completed his general surgery and urology training at Johns Hopkins and a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center. Dr. Gonzalgo is a recognized expert in DNA methylation and is particularly interested in developing new diagnostic and therapeutic approaches for cancer detection and treatment. He has carried out pioneering research on the molecular biology and early detection of prostate, bladder, and kidney cancer and has published extensively on the scientific and clinical aspects of these diseases.